Submitted by Anonymous (not verified) on 8 November 2023 - 9:48
Human medicines European public assessment report (EPAR): Fasenra, benralizumab, Asthma, Date of authorisation: 08/01/2018, Revision: 13, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Fasenra, benralizumab, Asthma, Date of authorisation: 08/01/2018, Revision: 13, Status: Authorised